Verastem: A Real Pancreatic Cancer Drug, Arriving Second

Verastem, a biopharmaceutical company, has developed a real drug for pancreatic cancer.

The drug, VS-6766, is expected to be approved in the second half of 2027.

The company's stock price has increased significantly on the news.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.